Advancements in Antifungal Treatment: Insights from In vitro Trials with Selenium Sulfide Dr. Kamal Kant Kohli30 Oct 2025 11:15 AM ISTFungal infections represent a significant challenge in human medicine. With increasing resistance to conventional antifungal therapies and the...
India's Unique CV Risk Profile: How to Decode the Role of Aspirin? Dr. Ajay U. Mahajan7 Oct 2025 11:47 AM ISTCardiovascular disease remains one of the dominant non-communicable causes of death in India, contributing substantially to premature morbidity and...
Identifying Aspirin Candidates for Primary Prevention: Focus on Men Aged 40- 50 with Metabolic Syndrome and Cardiometabolic Risk Lalhmangaihkimi29 Sept 2025 12:15 PM ISTUnique CV Risk in India- Epidemiological BackdropCardiovascular diseases (CVDs) remain the leading cause of death in India, with a WHO-reported...
Undenatured Collagen in Osteoarthritis Management: Practitioner's Review in 2025 Naresh Pincha22 Sept 2025 11:18 AM ISTOsteoarthritis is the most prevalent musculoskeletal disorder globally and the leading cause of chronic pain and disability. In India, over 62 million...
Exploring Buccal Prochlorperazine: A Targeted Review of Its Pharmacological Profile Dr. Kamal Kant Kohli9 Sept 2025 12:15 PM ISTThe Clinical Value of Buccal ProchlorperazineProchlorperazine remains a clinically valuable agent for managing nausea, dizziness, vertigo, and...
Overcoming Antifungal Resistance: The Case for Selenium Sulfide Dr. Kamal Kant Kohli5 Sept 2025 12:30 PM ISTThe rising incidence of fungal infections and increasing resistance to antifungal treatments present significant global health challenges, accompanied...
The Forgotten Insulin Sensitizer: Revisiting Pioglitazone for Metabolically Unhealthy Non-Obese (MUNO) Indians with T2DM Dr. Arvind Gupta25 Aug 2025 10:56 AM ISTMUNO Indian Phenotype: A Silent High-Risk Candidate The Metabolically Unhealthy Non-Obese (MUNO) phenotype is a silent but high-risk profile,...
Young, Diabetic, and at High CV Risk: Is It Time for Early Aspirin? Dr. Amit V. Joshi18 Aug 2025 11:47 AM ISTYoung, Diabetic, and at High CV Risk: A Case for Early CV Prevention with Aspirin in the High-Risk Young
Twelve Co-morbidities' Association and Risks Associated with Prediabetes-Evidence Every Clinician Must Know Dr. Ramdas Bharat Barure14 Aug 2025 10:50 AM ISTAugust 14 has been marked as World Prediabetes Day, set 90 days before World Diabetes Day (November 14), the typical timeframe needed to achieve a...
Addressing Ketoconazole Resistance: Exploring the Efficacy of Selenium Sulfide in Resistant Cases Dr. Kamal Kant Kohli5 Aug 2025 11:46 AM ISTSeborrheic dermatitis has long been treated with azoles, particularly ketoconazole, due to their effective antifungal and anti-inflammatory...
Penicillin-Binding Protein 3 Inserts in E.coli:A Growing Burden of Underreported Threat Dr. Kamal Kant Kohli31 July 2025 11:02 AM ISTIntroductionPenicillin-binding proteins (PBPs) synthesize and remodel the peptidoglycan layer of the bacterial cell wall, which maintain cell shape...
Uncontrolled T2D in India: Valuable Consideration for Dapagliflozin Sitagliptin Combination Dr. D.C. Sharma25 July 2025 12:11 PM ISTIndia accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India are living with diabetes,...
